AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10021718 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/kg porcine surfactant (Group A) in subgroup < 1500 grams
Number of subjects: 165
Study 10021718 — intervention group
Group type: COMPARATOR
Intervention: 100 mg/kg porcine surfactant (Group B) in subgroup < 1500 grams
Number of subjects: 165
Study 8402378 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive videodisc (IVD) instruction
Number of subjects: 0
Study 8402378 — intervention group
Group type: COMPARATOR
Intervention: Traditional instruction
Number of subjects: 0
Study 8402378 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of IVD and traditional instruction
Number of subjects: 0
Study 8402378 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional-lecture presentation first, followed by IVD instruction
Number of subjects: 0
Study 3490270 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of propofol during nitrous oxide anaesthesia
Number of subjects: 57
Study 29530781 — intervention group
Group type: EXPERIMENTAL
Intervention: NEI VFQ-25 composite score
Number of subjects: 100
Study 29530781 — intervention group
Group type: EXPERIMENTAL
Intervention: NEI VFQ-25 near activity score
Number of subjects: 100
Study 29530781 — intervention group
Group type: EXPERIMENTAL
Intervention: NEI VFQ-25 distance activity score
Number of subjects: 100
Study 29530781 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline NEI VFQ-25 composite score
Number of subjects: 100
Study 29530781 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline NEI VFQ-25 near activities score
Number of subjects: 100
Study 29530781 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline NEI VFQ-25 distance activities score
Number of subjects: 100
Study 29530781 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline mean NEI VFQ-25 scores
Number of subjects: 100
Study 27585768 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum‐formed retainer (Essix Ace plastic)
Number of subjects: 82
Study 27585768 — intervention group
Group type: COMPARATOR
Intervention: Bonded retainer (0.0175 coaxial archwire bonded with Transbond LR)
Number of subjects: 82
Study 25626738 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anaesthesia
Number of subjects: 0
Study 25626738 — intervention group
Group type: COMPARATOR
Intervention: Total intravenous anaesthesia (TIVA) with propofol/remifentanil
Number of subjects: 0
Study 24337423 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary functional restoration treatment with cognitive behavior therapy
Number of subjects: 681
Study 20486333 — intervention group
Group type: EXPERIMENTAL
Intervention: European D pteronyssinus extracts (3 extracts)
Number of subjects: 19
Study 20486333 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexican D pteronyssinus extract
Number of subjects: 19
Study 20486333 — intervention group
Group type: EXPERIMENTAL
Intervention: US-Mexican D pteronyssinus extract
Number of subjects: 19
Study 20486333 — intervention group
Group type: COMPARATOR
Intervention: Reference extract (FDA-approved extract)
Number of subjects: 19
Study 20486333 — intervention group
Group type: EXPERIMENTAL
Intervention: European extracts
Number of subjects: 19
Study 20486333 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexican extract
Number of subjects: 19
Study 18852547 — intervention group
Group type: EXPERIMENTAL
Intervention: High-velocity high-power training (POW)
Number of subjects: 57
Study 18852547 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional slow-velocity progressive resistance training (STR)
Number of subjects: 57
Study 18852547 — intervention group
Group type: COMPARATOR
Intervention: Control group of lower extremity stretching (CON)
Number of subjects: 57
Study 16740371 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist therapy
Number of subjects: 50
Study 16740371 — intervention group
Group type: COMPARATOR
Intervention: MRgFUS without pre-treatment
Number of subjects: 50
Study 12924676 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal Exposure with Cognitive Restructuring (IE/CR)
Number of subjects: 58
Study 12924676 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal Exposure (IE)
Number of subjects: 58
Study 12924676 — intervention group
Group type: COMPARATOR
Intervention: Supportive Counseling (SC)
Number of subjects: 58
Study 9915271 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mmol/L dialysate calcium solution
Number of subjects: 13
Study 9915271 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 mmol/L dialysate calcium solution
Number of subjects: 13
Study 8525396 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (25mg/kg body weight in one dose)
Number of subjects: 31
Study 2305760 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful transplantation (cyclosporine/prednisone therapy, N = 51)
Number of subjects: 766
Study 2305760 — intervention group
Group type: COMPARATOR
Intervention: Successful transplantation (conventional immunosuppressive therapy; antilymphocyte globulin/prednisone/azathioprine, N = 40)
Number of subjects: 766
Study 2305760 — intervention group
Group type: COMPARATOR
Intervention: Center hemodialysis
Number of subjects: 766
Study 2305760 — intervention group
Group type: COMPARATOR
Intervention: Continuous ambulatory peritoneal dialysis (CAPD)
Number of subjects: 766
Study 7023415 — intervention group
Group type: EXPERIMENTAL
Intervention: Men's group treatment for erectile dysfunction
Number of subjects: 21
Study 7023415 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 21
Study 30344863 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving training sessions (4 sessions)
Number of subjects: 257
Study 30344863 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 257
Study 26929110 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 2.5 mg
Number of subjects: 0
Study 26929110 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25317790 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 10 mg/kg, followed by 5 mg/kg after 24 and 48 hours
Number of subjects: 2
Study 25317790 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5% glucose)
Number of subjects: 2
Study 22638934 — intervention group
Group type: COMPARATOR
Intervention: Short-course radiotherapy (SC-RT) 29 Gy in 10 twice daily fractions followed by immediate surgery; n=108
Number of subjects: 225
Study 22638934 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-course radiochemotherapy (LC-RCHT) 54 Gy in 28 fractions with simultaneous 5-fluorouracil (5-FU) ± oxaliplatin chemotherapy followed by delayed surgery; n=117
Number of subjects: 225
Study 22638934 — intervention group
Group type: COMPARATOR
Intervention: Long-course radiochemotherapy (LC-RCHT)
Number of subjects: 225
Study 22638934 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (SC-RT)
Number of subjects: 225
Study 20375695 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF) after failed EndoCinch gastroplication
Number of subjects: 11
Study 17084393 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH‐agonist/rFSH
Number of subjects: 73
Study 17084393 — intervention group
Group type: COMPARATOR
Intervention: GnRH‐antagonist/rFSH
Number of subjects: 73
Study 16186521 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator-based training
Number of subjects: 83
Study 16186521 — intervention group
Group type: COMPARATOR
Intervention: Driving-related cognitive tasks (Control)
Number of subjects: 83
Study 12394603 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuffed tunneled hemodialysis catheters
Number of subjects: 0
Study 12394603 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter replacement or intervention
Number of subjects: 0
Study 12394603 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 10921042 — intervention group
Group type: COMPARATOR
Intervention: TACE
Number of subjects: 102
Study 10921042 — intervention group
Group type: EXPERIMENTAL
Intervention: TACE combined with ITLE
Number of subjects: 102
Study 8207601 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracordal injection therapy with atelocollagen (submucosal injection)
Number of subjects: 20
Study 8207601 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracordal injection therapy with atelocollagen (intramuscular injection)
Number of subjects: 20
Study 2563321 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg pirbuterol thrice daily
Number of subjects: 11
Study 2563321 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical-appearing)
Number of subjects: 11
Study 4607845 — intervention group
Group type: EXPERIMENTAL
Intervention: Ancrod therapy
Number of subjects: 49
Study 4607845 — intervention group
Group type: COMPARATOR
Intervention: Control (no therapy)
Number of subjects: 49
Study 29855660 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-fluoroamphetamine (100 mg)
Number of subjects: 12
Study 29855660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 27993758 — intervention group
Group type: EXPERIMENTAL
Intervention: BMSmod (bare metal cobalt‐chromium stent with an active surface oxide layer modification)
Number of subjects: 31
Study 27993758 — intervention group
Group type: EXPERIMENTAL
Intervention: BMSmod
Number of subjects: 31
Study 26020389 — intervention group
Group type: EXPERIMENTAL
Intervention: ETView VivaSight SL
Number of subjects: 107
Study 26020389 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope (MAC)
Number of subjects: 107
Study 23950589 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 40
Study 23391831 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) plus 0.5% AZM gel
Number of subjects: 30
Study 23391831 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) only
Number of subjects: 30
Study 19663110 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligopeptide (Lumixyl) 0.01% w/w, applied twice daily for 16 weeks
Number of subjects: 5
Study 19663110 — intervention group
Group type: COMPARATOR
Intervention: Placebo (not specified)
Number of subjects: 5
Study 16699358 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief education and counseling intervention delivered by a nurse
Number of subjects: 3500
Study 16699358 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 3500
Study 14724157 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic therapy (Lactobacillus acidophilus La5, Bifidobacterium lactis Bb‐12, Streptococcus thermophilus, Lactobacillus bulgaricus, and oligofructose)
Number of subjects: 137
Study 14724157 — intervention group
Group type: COMPARATOR
Intervention: Placebo (placebo capsules and sucrose powder)
Number of subjects: 137
Study 14724157 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic therapy
Number of subjects: 137
Study 14724157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study 11752509 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable radiometer (Cyclops)
Number of subjects: 37
Study 11752509 — intervention group
Group type: COMPARATOR
Intervention: Thermal imager (Starsight)
Number of subjects: 37
Study 9031265 — intervention group
Group type: EXPERIMENTAL
Intervention: Donor-specific transfusion (DST)
Number of subjects: 30
Study 9031265 — intervention group
Group type: COMPARATOR
Intervention: Control (no DST)
Number of subjects: 30
Study 9031265 — intervention group
Group type: EXPERIMENTAL
Intervention: Donor-specific transfusion (DST) in hyperresponder patients
Number of subjects: 30
Study 9031265 — intervention group
Group type: COMPARATOR
Intervention: Control (no DST) in hyperresponder patients
Number of subjects: 30
Study 8582091 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic extract
Number of subjects: 0
Study 8582091 — intervention group
Group type: COMPARATOR
Intervention: Garlic extract (in vitro)
Number of subjects: 0
Study 2549261 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g of ascorbic acid (vitamin C)/day plus 400 mg of alpha‐tocopherol (vitamin E)/day plus 22.5 g/day of grain fiber supplement
Number of subjects: 58
Study 2549261 — intervention group
Group type: COMPARATOR
Intervention: 4 g of ascorbic acid (vitamin C)/day plus 400 mg of alpha‐tocopherol (vitamin E)/day alone
Number of subjects: 58
Study 781235 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoprofen
Number of subjects: 24
Study 781235 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 24
Study 781235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 28315149 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofunctional therapy (MT)
Number of subjects: 54
Study 24843060 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 µg Engerix‐B
Number of subjects: 0
Study 24843060 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 µg Engerix‐B
Number of subjects: 0
Study 24843060 — intervention group
Group type: COMPARATOR
Intervention: Baseline (no challenge dose)
Number of subjects: 0
Study 22670051 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial tachyarrhythmias
Number of subjects: 2580
Study 20146702 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole-Mg 20.6 mg
Number of subjects: 40
Study 20146702 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole 15 mg
Number of subjects: 40
Study 18434902 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (50 mg single bolus)
Number of subjects: 75
Study 18434902 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (50 mg every 6 hrs) plus Fludrocortisone (50 microg daily)
Number of subjects: 75
Study 18434902 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 75
Study 18434902 — intervention group
Group type: COMPARATOR
Intervention: Patients with normal adrenal function (control group)
Number of subjects: 75
Study 16215921 — intervention group
Group type: EXPERIMENTAL
Intervention: Philips FAST pulse oximeter
Number of subjects: 36
Study 16215921 — intervention group
Group type: COMPARATOR
Intervention: Masimo SET pulse oximeter
Number of subjects: 36
Study 12022525 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary shunt
Number of subjects: 40
Study 12022525 — intervention group
Group type: COMPARATOR
Intervention: Proximal coronary artery occluded by a soft snare
Number of subjects: 40
Study 12022525 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups during grafting of the posterior descending coronary artery
Number of subjects: 40
Study 12022525 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups during grafting of the circumflex coronary artery
Number of subjects: 40
Study 10335903 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone 200 mg per day
Number of subjects: 24
Study 10335903 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone 600 mg per day
Number of subjects: 24
Study 10335903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 7828379 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin‐3 (rhIL‐3) 2.5 micrograms/kg/day
Number of subjects: 18
Study 7828379 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin‐3 (rhIL‐3) 5.0 micrograms/kg/day
Number of subjects: 18
Study 7828379 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin‐3 (rhIL‐3) 7.5 micrograms/kg/day
Number of subjects: 18
Study 7828379 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin‐3 (rhIL‐3)
Number of subjects: 18
Study 2165888 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet with isocaloric addition of 1 g of meat protein day‐1 kg‐1
Number of subjects: 8
Study 2165888 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet with addition of 170 mmol of sodium chloride/day
Number of subjects: 8
Study 2165888 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet with both additions (protein and sodium)
Number of subjects: 8
Study 2165888 — intervention group
Group type: COMPARATOR
Intervention: Basal diet (control)
Number of subjects: 8
Study 373735 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical manipulation performed by a medical practitioner or physiotherapist
Number of subjects: 85
Study 373735 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical manipulation performed by a chiropractor
Number of subjects: 85
Study 373735 — intervention group
Group type: COMPARATOR
Intervention: Mobilization performed by a medical practitioner or physiotherapist (Control)
Number of subjects: 85
Study 373735 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical manipulation (Chiropractor)
Number of subjects: 85
Study 31573935 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile text messaging intervention
Number of subjects: 4378
Study 31573935 — intervention group
Group type: COMPARATOR
Intervention: Email intervention
Number of subjects: 4378
Study 27345629 — intervention group
Group type: EXPERIMENTAL
Intervention: Folk recreation program (40 to 50 minutes, 3 times a week for 16 weeks)
Number of subjects: 48
Study 27345629 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 48
Study 26082974 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunct minocycline (100 mg oral capsule twice daily; n = 29)
Number of subjects: 52
Study 26082974 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunct minocycline
Number of subjects: 52
Study 26082974 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 23)
Number of subjects: 52
Study 26082974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 23071082 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) - 2 sessions
Number of subjects: 212
Study 23071082 — intervention group
Group type: COMPARATOR
Intervention: No motivational interviewing (Control group)
Number of subjects: 212
Study 21730224 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g/d of plant sterols (PS)
Number of subjects: 82
Study 21730224 — intervention group
Group type: COMPARATOR
Intervention: Control (without plant sterols)
Number of subjects: 82
Study 19054288 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal appliance treatment
Number of subjects: 39
Study 16739842 — intervention group
Group type: EXPERIMENTAL
Intervention: Jingjin therapy
Number of subjects: 100
Study 16739842 — intervention group
Group type: COMPARATOR
Intervention: Nimodipine (control)
Number of subjects: 100
Study 15589061 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol 100 mg three times a day for 14 days
Number of subjects: 41
Study 15589061 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 15589061 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol and Placebo
Number of subjects: 41
Study 11395699 — intervention group
Group type: EXPERIMENTAL
Intervention: Twin-block appliance with labial bow (TB1)
Number of subjects: 63
Study 11395699 — intervention group
Group type: EXPERIMENTAL
Intervention: Twin-block appliance with high-pull headgear and torquing spurs (TB2)
Number of subjects: 63
Study 9422898 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan 60 mg
Number of subjects: 24
Study 9422898 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan 120 mg
Number of subjects: 24
Study 9422898 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 9422898 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Number of subjects: 24
Study 8280549 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 50
Study 8280549 — intervention group
Group type: COMPARATOR
Intervention: Control (no electroacupuncture)
Number of subjects: 50
Study 3544782 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment (streptokinase) for anterior AMI
Number of subjects: 488
Study 3544782 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment (streptokinase) for anterior AMI with Q waves
Number of subjects: 488
Study 3544782 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment (streptokinase) for anterior AMI with high ST elevation
Number of subjects: 488
Study 3544782 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment for inferior AMI
Number of subjects: 488
Study 3544782 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment for inferior AMI with high ST-segment elevation
Number of subjects: 488
Study 3544782 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment for inferior AMI with marked contralateral ST-segment depression
Number of subjects: 488
Study 3544782 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment for anterior AMI
Number of subjects: 488
Study 3544782 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment for inferior AMI
Number of subjects: 488
Study 31679738 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-use duodenoscope
Number of subjects: 6
Study 31679738 — intervention group
Group type: COMPARATOR
Intervention: Reusable duodenoscopes
Number of subjects: 6
Study 29588314 — intervention group
Group type: EXPERIMENTAL
Intervention: Active therapy
Number of subjects: 4000
Study 29588314 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent-event methods
Number of subjects: 4000
Study 29588314 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-to-first methods
Number of subjects: 4000
Study 29588314 — intervention group
Group type: COMPARATOR
Intervention: Cox model
Number of subjects: 4000
Study 27049908 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate weight‐bearing‐as‐tolerated (WBAT)
Number of subjects: 88
Study 27049908 — intervention group
Group type: COMPARATOR
Intervention: Non‐weight‐bearing for the first 6 postoperative weeks (NWB)
Number of subjects: 88
Study 24323062 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (0.9% sodium chloride) solution
Number of subjects: 360
Study 24323062 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline (0.9% sodium chloride) solution with added gentamicin (80 mg/L)
Number of subjects: 360
Study 22871888 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blocker
Number of subjects: 4396
Study 22871888 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic
Number of subjects: 4396
Study 22871888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4396
Study 22871888 — intervention group
Group type: EXPERIMENTAL
Intervention: Variability in SBP
Number of subjects: 4396